Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Regen BioPharma, Inc. (RGBPP)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.06250.0000 (0.00%)
At close: 12:54PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0625
Open0.0650
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0608 - 0.0660
52 Week Range0.0012 - 0.3884
Volume720,949
Avg. Volume2,421,487
Market Cap2.333M
Beta (5Y Monthly)4.13
PE Ratio (TTM)N/A
EPS (TTM)-0.0010
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for RGBPP

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • REGEN BIOPHARMA INC
    Analyst Report: QIAGEN N.V.Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates over 85% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (44% of 2020 sales), followed by EMEA (36%) and Asia-Pacific (19%).
    Rating
    Fair Value
    Economic Moat
    25 days agoMorningstar
View more
Advertisement
Advertisement